Akèy › Limfòm Burkitt › Florid › Miami

Etid klinik pou Limfòm Burkitt nan Miami, FL

4 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

366 Days – 46 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Nicklaus Children's Hospital, Miami

365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Ap rekriteFaz 2

Nicklaus Children's Hospital, Miami

Laj 1 a 25 · Tout sèks · Mizajou May 4, 2025 · NCT03509961

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.